Respiratory syncytial virus mRNA vaccine(Ab&B Bio-tech)

呼吸道合胞病毒mRNA疫苗（江苏中慧元通生物科技）

Report date: 2026/05/07 16:12:05

Base Information

Drug NameRespiratory syncytial virus mRNA vaccine(Ab&B Bio-tech)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsMonkeypox

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAb&B Bio-tech Co Ltd JS

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAb&B Bio-tech Co Ltd JS

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus InfectionsMonkeypox

Inactive IndicationsN/A

Other Information

ATC CodeN/A